Abstract:
F uzzle is an innovative, patent-pending weight loss system designed to address habitual and emotional eating through a novel intraoral device and personalized support. Unlike traditional approaches that rely on medications or restrictive diets, Fuzzle provides a drug- free solution by disrupting sensory reinforcement pathways tied to cravings and non-essential eating. The device creates separations in the mouth, particularly preventing the tongue from contacting the teeth. This reduces the sensory amplification of food cues and helps decrease the automatic responses that drive overeating and food noise. Fuzzle is currently pending FDA approvals for the treatment of obesity as a Class II medical device. The program is positioned as an ideal step therapy prior to the use of GLP-1 medications and as an after-care option for individuals who have already lost weight and want to sustain results while building healthier long-term habits. The system emphasizes human connection and accountability. Users meet one-on-one with a registered dietitian via weekly video or phone calls to track progress, measure changes in weight and body composition, and celebrate successes. Between sessions, users are supported by their assigned Fuzzle team member, who provides direct 24/7 messaging through the app. Meal plans are developed in collaboration with the dietitian and updated with AI assistance for ongoing personalization. Early users have reported body weight reduction of up to 1.5 percent per month, along with a noticeable decrease in food noise and cravings. By focusing on sensory pathways rather than hormonal manipulation, Fuzzle introduces a behavioral and physiological reset that empowers individuals to make healthier food choices. Looking forward, future enhancements may include adherence-tracking sensors and expanded applications in oral wellness. As the prevalence of obesity continues to rise, Fuzzle represents a promising intervention that leverages the intersection of AI technology and behavioral modification to address a critical public health challenge
